These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 12387461)

  • 1. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A; Vollenhoven B; Sowter M
    BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Farquhar C; Brown PM; Furness S
    BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis.
    de Milliano I; Twisk M; Ket JC; Huirne JA; Hehenkamp WJ
    PLoS One; 2017; 12(10):e0186158. PubMed ID: 29036173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
    Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
    Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Sowter MC; Lethaby A; Singla AA
    Cochrane Database Syst Rev; 2002; (3):CD001124. PubMed ID: 12137619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
    Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
    Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ; Pearce P; Herington AC; Healy DL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy and myomectomy by laparotomy.
    West CP
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):317-35. PubMed ID: 10023424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
    Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
    Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha AS; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005073. PubMed ID: 16437515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study).
    Kitade M; Kumakiri J; Kobori H; Murakami K
    Trials; 2024 May; 25(1):343. PubMed ID: 38790029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
    de Milliano I; Huirne JAF; Thurkow AL; Radder C; Bongers MY; van Vliet H; van de Lande J; van de Ven PM; Hehenkamp WJK
    Acta Obstet Gynecol Scand; 2020 Jan; 99(1):89-98. PubMed ID: 31468503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Sharma M; Buck L; Mastrogamvrakis G; Kontos K; Magos A; Taylor A
    BJOG; 2003 Jul; 110(7):712; author reply 712-3. PubMed ID: 12842071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.